EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Patient‐Derived iPSC ‐ MSC Modelling Reveals Reversible GSK3 ‐Mediated Suppression of Mesenchymal Lineage Differentiation in Legg‐Calvé‐Perthes Disease

Binna Seol, Hyung Jin Lim iD, Cho Lok Song, Jungwoon Lee, Yee Sook Cho iD

Journal of Cellular and Molecular Medicine · 2026

DOI: 10.1111/jcmm.71350 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2026. Verfasst von Binna Seol und 4 weiteren Autor:innen. Beteiligte Einrichtung: Stem Cell Research Laboratory, Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea. Hauptthemen laut MEDLINE: Mesenchymal Stem Cells, Induced Pluripotent Stem Cells, Cell Differentiation, Legg-Calve-Perthes Disease. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Korean Fund for Regenerative Medicine, KRIBB Research Initiative Program, National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Legg‐Calvé‐Perthes disease (LCPD) is an idiopathic paediatric osteonecrosis characterized by avascular injury to the femoral head, resulting in structural collapse and early osteoarthritis. Although mesenchymal stem cell (MSC) dysfunction has been implicated, the underlying mechanisms remain unclear due to the absence of human disease models. Here, we generated patient‐specific induced pluripotent stem cells (iPSCs) from dermal fibroblasts of LCPD patients and differentiated them into mesenchymal stem cells (iMSCs) to establish an in vitro platform for mechanistic interrogation. LCPD‐iMSCs exhibited hallmark disease‐associated phenotypes, including concurrent suppression of osteogenic, adipogenic and chondrogenic differentiation, accompanied by enhanced phosphorylation of GSK3α/β, reduced β‐catenin abundance and attenuated canonical Wnt signalling. Transcriptomic analyses revealed alterations in extracellular matrix organization, adhesion pathways and PI3K‐Akt/MAPK signalling, consistent with a cellular environment predisposed to impaired mesenchymal function. Pharmacological inhibition of GSK3 using lithium chloride restored β‐catenin levels, improved osteogenic and adipogenic marker expression, and enhanced matrix deposition, demonstrating functional reversibility of the LCPD phenotype. These findings identify GSK3‐mediated β‐catenin destabilization as a central regulator of MSC lineage impairment in LCPD and establish a patient‐derived iPSC‐MSC model as a valuable platform for mechanistic and therapeutic exploration in paediatric osteonecrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesenchymal Stem CellsInduced Pluripotent Stem CellsCell DifferentiationLegg-Calve-Perthes DiseaseGlycogen Synthase Kinase 3Models, BiologicalCell LineageHumansbeta CateninOsteogenesisWnt Signaling PathwayGlycogen Synthase Kinase 3 betaChondrogenesisAdipogenesis

Stichwörter der Autor:innen

GSK‐3βLegg‐Calvé‐Perthes diseaseWnt signallingiPSCmesenchymal stem cell

Substanzen

Glycogen Synthase Kinase 3beta CateninGlycogen Synthase Kinase 3 beta

Autor:innen und Institutionen

  • Stem Cell Research Laboratory, Immunotherapy Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.
  • Department of Bioscience, KRIBB School, University of Science & Technology, Daejeon, South Korea.
  • Stem Cell & Regenerative Biology Laboratory, Environmental Disease Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon, South Korea.

ORCID-Profile: Hyung Jin Lim, Yee Sook Cho

Förderung

  • Korean Fund for Regenerative Medicine
  • KRIBB Research Initiative Program
  • National Research Foundation of Korea (NRF)

Zitieren

APA

Seol, B., Lim, H. J., Song, C. L., Lee, J., & Cho, Y. S. (2026). Patient‐Derived iPSC ‐ MSC Modelling Reveals Reversible GSK3 ‐Mediated Suppression of Mesenchymal Lineage Differentiation in Legg‐Calvé‐Perthes Disease. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.71350

Vancouver

Seol B, Lim HJ, Song CL, Lee J, Cho YS. Patient‐Derived iPSC ‐ MSC Modelling Reveals Reversible GSK3 ‐Mediated Suppression of Mesenchymal Lineage Differentiation in Legg‐Calvé‐Perthes Disease. Journal of Cellular and Molecular Medicine. 2026. doi:10.1111/jcmm.71350

BibTeX
@article{Seol2026,
  author = {Seol, Binna and Lim, Hyung Jin and Song, Cho Lok and Lee, Jungwoon and Cho, Yee Sook},
  title = {Patient‐Derived iPSC ‐ MSC Modelling Reveals Reversible GSK3 ‐Mediated Suppression of Mesenchymal Lineage Differentiation in Legg‐Calvé‐Perthes Disease},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2026},
  doi = {10.1111/jcmm.71350}
}
Kostenlos starten →